Current Headlines
-
Singapore Single-Cell Research Center Opens Door For Asian Biological Discoveries
4/15/2013
Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.
-
Reading And Imaging Are Combined In BioTek's Revolutionary, New Cytation™3
4/15/2013
BioTek continues providing unique solutions and technological advancements in microplate instrumentation by proudly announcing the first combination Hybrid multi-mode microplate reader and imaging system — the Cytation™3 Cell Imaging Multi-Mode Reader! By combining multi-detection and automated digital microscopy in one instrument, cell biology researchers can now glean data-rich quantitative and qualitative information from their cells like never before.
-
Air Products To Highlight Advanced Liquid Nitrogen Technologies At INTERPHEX 2013
4/15/2013
Air Products, a leading industrial gas supplier and cryogenic solutions provider, will highlight its wide range of advanced liquid nitrogen (LIN) technologies at INTERPHEX 2013 in New York City from April 23-25.
-
Novavax To Review Recent Findings From Vaccine Programs At World Vaccine Congress And Expo In Washington, DC
4/15/2013
Novavax, Inc. (Nasdaq:NVAX) announced today that it will review recent clinical results from the company's vaccine development programs at the World Vaccine Congress and Expo this week in Washington, DC.
-
ApothéCure, Inc. Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By ApothéCure, Inc. Due To Sterility Assurance Concerns
4/15/2013
ApothéCure, Inc. is voluntarily recalling all lots of sterile products compounded by the pharmacy that are not expired to the user level. The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes.
-
Sanofi And PATH Announce The Launch Of Large-Scale Production Of Semisynthetic Artemisinin Against Malaria
4/12/2013
Sanofi (Euronext: SAN and NYSE: SNY) and PATH’s Drug Development program, established through an affiliation with OneWorld Health, today announced the launch of the large-scale production line of semisynthetic artemisinin at Sanofi’s Garessio site in Italy.
-
ATMI And Disposable-Lab Introduce First Single-Use Platform For Fill/Finish Operations
4/12/2013
ATMI, Inc., a global technology company and a leader in single-use process solutions, recently introduced the first all-single-use fill/finish platform for pharmaceutical and biopharmaceutical applications that is compliant with current good manufacturing practices (cGMP).
-
Otsuka's New Drug Application For Tolvaptan, The Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted for Review By The US Food And Drug Administration (FDA)
4/12/2013
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review the company's new drug application (NDA) for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).
-
Emergent BioSolutions Presents Efficacy Data On ES210; A Bispecific ADAPTIR Molecule For Treating Autoimmune Diseases
4/11/2013
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has presented data on ES210, one of its bispecific ADAPTIRTM (Modular Protein Technology) molecules, that is targeting autoimmune disease at Keystone Symposia’s Advances in the Knowledge and Treatment of Autoimmunity in Whistler, British Columbia, Canada.
-
2013 BIO International Convention To Host Alzheimer’s Forum
4/11/2013
According to the Alzheimer’s Association, in 2013, the disease will cost the nation $203 billion and this number is expected to rise to $1.2 trillion by 2050.